실적분석 2026년 8월 27일

HealthEquity ($HQY) FY2027 Q2 Earnings Analysis — Adjusted EPS of $1.24 Beats Estimates, Full-Year Guidance Raised

Earnings Scorecard

Revenue: $350.7 million (+8% year over year, estimate $349 million) ✅ Beat

EPS (Earnings Per Share): Adjusted basis $1.24 (estimate $1.19) ✅ Beat

Guidance: Raised — FY2027 revenue $1.411 billion–$1.421 billion, adjusted EBITDA $628 million–$636 million

Stock Reaction: Extended hours -0.87% ($103.51) — as of 08-27 20:43 Korea time

Highlights

Record profitability: Adjusted EBITDA margin 48% in FY2027 Q2, up from 46% a year earlier

Surge in new accounts: 202,000 new HSA (Health Savings Account) sales in the quarter, +24% year over year

Assets up 14%: Total HSA assets $37.9 billion, of which $20.6 billion in investment assets

With account counts rising alongside the funds accumulating within them, profits grew faster than revenue even as revenue expanded at single-digit pace. The company also repurchased $108.11 million of stock during the quarter, bolstering shareholder returns.

Misses

Revenue beat was thin: $350.7 million just barely above the $349 million estimate

Guidance raise of only about $1 million: Effectively a sideways revision from the prior $1.410 billion–$1.420 billion range

GAAP net income +10%: $65.6 million, a growth rate lower than the revenue and margin improvements

The numbers topped estimates but not by enough to surprise the market. Custodial fees on the $17.4 billion in cash sitting in accounts make up roughly half of revenue, so if interest rates fall, sustaining the margin peak will prove difficult.

What the Company Said

Management framed the quarter as one that refreshed records across margin, account count, and assets, and raised the FY2027 outlook on that confidence. The market weighed more heavily the fact that the raise was not large.

Market Reaction and Key Points Ahead

The reason the stock dipped modestly in extended trading despite the beat is that the lift to full-year guidance was slim relative to expectations already baked into the share price.

Whether custodial fee revenue from the $17.4 billion in cash parked in accounts can sustain growth even as interest rates decline

Whether the +24% surge in new sales accounts extends into the second-half enrollment season

Whether the 48% adjusted EBITDA margin is a one-off or holds into the next quarter